- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis C virus-related cryoglobulinemic vasculitis
Authors
Keywords
-
Journal
MINERVA MEDICA
Volume 112, Issue 2, Pages -
Publisher
Edizioni Minerva Medica
Online
2021-04-08
DOI
10.23736/s0026-4806.20.07120-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy
- (2020) Cesare Mazzaro et al. AUTOIMMUNITY REVIEWS
- Direct‐acting antiviral agents for hepatitis C virus‐mixed cryoglobulinaemia: dissociated virological and haematological responses
- (2020) Gabriele Pozzato et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long‐lasting persistence of large B‐cell clones in hepatitis C virus‐cured patients with complete response of mixed cryoglobulinaemia vasculitis
- (2019) Marcella Visentini et al. LIVER INTERNATIONAL
- Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome
- (2019) Massimo Galli et al. AUTOIMMUNITY REVIEWS
- Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence
- (2019) Fabrizi et al. Pathogens
- Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis
- (2018) Patrice Cacoub et al. Clinical Gastroenterology and Hepatology
- Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure
- (2018) Martín Bonacci et al. GASTROENTEROLOGY
- Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer
- (2018) Marcella Visentini et al. RHEUMATOLOGY
- Apheresis treatment of cryoglobulinemic vasculitis: a multicentre cohort study of 159 patients
- (2018) P. Marson et al. TRANSFUSION AND APHERESIS SCIENCE
- Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience
- (2018) Matteo Passerini et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Cryoglobulinaemia
- (2018) Dario Roccatello et al. Nature Reviews Disease Primers
- A pangenotypic, single tablet regimen of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C infection
- (2017) Ilan S. Weisberg et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis
- (2017) David Saadoun et al. GASTROENTEROLOGY
- Glecaprevir + pibrentasvir (ABT493 + ABT-530) for the treatment of Hepatitis C
- (2017) Hope Hubbard et al. Expert Review of Gastroenterology & Hepatology
- Hepatitis C virus and cardiovascular: A review
- (2017) Salvatore Petta Journal of Advanced Research
- Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study
- (2016) Dario Roccatello et al. AMERICAN JOURNAL OF NEPHROLOGY
- Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia
- (2016) Laura Gragnani et al. HEPATOLOGY
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue
- (2016) Joseph Schwartz et al. JOURNAL OF CLINICAL APHERESIS
- Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy: Table 1
- (2016) Salvatore Sollima et al. RHEUMATOLOGY
- Grazoprevir/elbasvir combination therapy for HCV infection
- (2016) Anaïs Vallet-Pichard et al. Therapeutic Advances in Gastroenterology
- Cryoglobulinemia Vasculitis
- (2015) Patrice Cacoub et al. AMERICAN JOURNAL OF MEDICINE
- Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study
- (2015) David Saadoun et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study
- (2015) Laura Gragnani et al. HEPATOLOGY
- Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents
- (2015) Meghan E. Sise et al. HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2015
- (2015) JOURNAL OF HEPATOLOGY
- PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis
- (2015) David Saadoun et al. JOURNAL OF HEPATOLOGY
- Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview
- (2015) Luigi Elio Adinolfi WORLD JOURNAL OF GASTROENTEROLOGY
- Extrahepatic manifestations of chronic hepatitis C virus infection
- (2014) Patrice Cacoub et al. DIGESTIVE AND LIVER DISEASE
- Hepatitis C virus associated glomerulopathies
- (2014) Abdullah Ozkok WORLD JOURNAL OF GASTROENTEROLOGY
- Associations of chronic hepatitis C with metabolic and cardiac outcomes
- (2013) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Epidemiology and natural history of HCV infection
- (2013) Behzad Hajarizadeh et al. Nature Reviews Gastroenterology & Hepatology
- A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis
- (2011) Michael C. Sneller et al. ARTHRITIS AND RHEUMATISM
- A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
- (2011) S. De Vita et al. ARTHRITIS AND RHEUMATISM
- A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection
- (2011) Marcella Visentini et al. AUTOIMMUNITY REVIEWS
- Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients
- (2011) Maurizio Pietrogrande et al. AUTOIMMUNITY REVIEWS
- Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: Results of multicenter cohort study and review of the literature
- (2011) C. Ferri et al. AUTOIMMUNITY REVIEWS
- The cryoglobulinaemias
- (2011) Manuel Ramos-Casals et al. LANCET
- Pegylated interferon- , ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study
- (2010) F. Dammacco et al. BLOOD
- Rituximab plus Peg-interferon- /ribavirin compared with Peg-interferon- /ribavirin in hepatitis C-related mixed cryoglobulinemia
- (2010) D. Saadoun et al. BLOOD
- Practical considerations on the use of rituximab in autoimmune neurological disorders
- (2010) Mixalis L. Kosmidis et al. Therapeutic Advances in Neurological Disorders
- Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia
- (2009) Claudia Stefanutti et al. JOURNAL OF CLINICAL APHERESIS
- Rituximab in cryoglobulinemic peripheral neuropathy
- (2009) Roberto Cavallo et al. JOURNAL OF NEUROLOGY
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Relapse of hepatitis C virus–associated mixed cryoglobulinemia vasculitis in patients with sustained viral response
- (2008) Dan-Avi Landau et al. ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More